1. Home
  2. AMWL vs GLSI Comparison

AMWL vs GLSI Comparison

Compare AMWL & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMWL
  • GLSI
  • Stock Information
  • Founded
  • AMWL 2006
  • GLSI 2006
  • Country
  • AMWL United States
  • GLSI United States
  • Employees
  • AMWL N/A
  • GLSI N/A
  • Industry
  • AMWL Retail: Computer Software & Peripheral Equipment
  • GLSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMWL Technology
  • GLSI Health Care
  • Exchange
  • AMWL Nasdaq
  • GLSI Nasdaq
  • Market Cap
  • AMWL 165.1M
  • GLSI 159.8M
  • IPO Year
  • AMWL 2020
  • GLSI 2020
  • Fundamental
  • Price
  • AMWL $11.74
  • GLSI $11.95
  • Analyst Decision
  • AMWL Hold
  • GLSI Strong Buy
  • Analyst Count
  • AMWL 6
  • GLSI 1
  • Target Price
  • AMWL $11.90
  • GLSI $38.00
  • AVG Volume (30 Days)
  • AMWL 90.5K
  • GLSI 24.6K
  • Earning Date
  • AMWL 02-12-2025
  • GLSI 04-14-2025
  • Dividend Yield
  • AMWL N/A
  • GLSI N/A
  • EPS Growth
  • AMWL N/A
  • GLSI N/A
  • EPS
  • AMWL N/A
  • GLSI N/A
  • Revenue
  • AMWL $254,364,000.00
  • GLSI N/A
  • Revenue This Year
  • AMWL $25.21
  • GLSI N/A
  • Revenue Next Year
  • AMWL $7.96
  • GLSI N/A
  • P/E Ratio
  • AMWL N/A
  • GLSI N/A
  • Revenue Growth
  • AMWL N/A
  • GLSI N/A
  • 52 Week Low
  • AMWL $5.00
  • GLSI $10.52
  • 52 Week High
  • AMWL $22.60
  • GLSI $21.44
  • Technical
  • Relative Strength Index (RSI)
  • AMWL 57.59
  • GLSI 40.69
  • Support Level
  • AMWL $11.18
  • GLSI $11.87
  • Resistance Level
  • AMWL $12.95
  • GLSI $12.95
  • Average True Range (ATR)
  • AMWL 0.81
  • GLSI 0.59
  • MACD
  • AMWL -0.04
  • GLSI -0.05
  • Stochastic Oscillator
  • AMWL 57.90
  • GLSI 25.19

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.

Share on Social Networks: